jilicc
Trump's lawyers rebuff DA's idea for upholding his hush money conviction
Evolus, Inc. ( NASDAQ:EOLS – Get Free Report ) CFO Sandra Beaver sold 1,586 shares of the firm’s stock in a transaction on Monday, December 23rd. The shares were sold at an average price of $10.85, for a total transaction of $17,208.10. Following the completion of the transaction, the chief financial officer now directly owns 146,916 shares in the company, valued at approximately $1,594,038.60. This represents a 1.07 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website . Evolus Stock Performance NASDAQ:EOLS opened at $11.09 on Friday. The firm has a 50-day moving average of $13.46 and a two-hundred day moving average of $13.73. The company has a debt-to-equity ratio of 20.58, a current ratio of 2.47 and a quick ratio of 2.23. The stock has a market cap of $702.23 million, a P/E ratio of -12.19 and a beta of 1.27. Evolus, Inc. has a 1-year low of $9.80 and a 1-year high of $17.82. Institutional Inflows and Outflows Several institutional investors have recently modified their holdings of EOLS. Bank of New York Mellon Corp increased its holdings in Evolus by 24.6% during the 2nd quarter. Bank of New York Mellon Corp now owns 181,093 shares of the company’s stock worth $1,965,000 after purchasing an additional 35,760 shares during the last quarter. Rhumbline Advisers grew its position in shares of Evolus by 27.3% during the second quarter. Rhumbline Advisers now owns 81,439 shares of the company’s stock worth $884,000 after buying an additional 17,442 shares in the last quarter. Arizona State Retirement System grew its position in shares of Evolus by 9.4% during the second quarter. Arizona State Retirement System now owns 14,603 shares of the company’s stock worth $158,000 after buying an additional 1,253 shares in the last quarter. Quest Partners LLC bought a new stake in shares of Evolus in the second quarter worth $43,000. Finally, Sei Investments Co. raised its holdings in Evolus by 9.8% in the second quarter. Sei Investments Co. now owns 33,802 shares of the company’s stock valued at $367,000 after acquiring an additional 3,020 shares in the last quarter. Institutional investors and hedge funds own 90.69% of the company’s stock. Wall Street Analyst Weigh In Check Out Our Latest Report on Evolus Evolus Company Profile ( Get Free Report ) Evolus, Inc, a performance beauty company, focuses on delivering products in the cash-pay aesthetic market in the United States, Canada, and Europe. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. Further Reading Receive News & Ratings for Evolus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolus and related companies with MarketBeat.com's FREE daily email newsletter .
Rivers APC: ‘Judgement nullifying congresses will not stand’ – OkochaNatural Gas Services Group, Inc. Announces the Retirement and Resignation of David Bradshaw from its Board of Directors
Article content A Federal Court judge has dismissed an appeal by a “deeply religious” B.C. health executive who said he was wrongfully denied employment insurance after being fired three years ago for refusing to get the COVID-19 vaccine. Darold Sturgeon was fired as executive director of medical affairs for Interior Health in November 2021 after refusing to get the vaccine based on his Christian beliefs. He applied for employment insurance benefits but was denied due to being fired for “misconduct,” with appeals to two levels of the Social Security Tribunal also failing, leading him to seek a judicial review in Federal Court in August 2023. The ruling says Sturgeon believed the tribunal should have examined his assertion under the Charter of Rights and Freedoms that the term “misconduct” did not apply to his case “because he was exercising his freedom of religion.” Justice William Pentney says “recent, abundant and unanimous case law” defined a specific and narrow role for the tribunal’s appeal divisions, focusing on an employee’s conduct, and not justification for and employer’s policies or compliance with the Charter. The ruling says Sturgeon’s appeal fell “outside the mandate” of the tribunal and he could have challenged Interior Health’s mandatory vaccine police “through other avenues.” These included advancing a Charter claim, lodging a wrongful dismissal suit or labour grievance, or complaining to the B.C. Human Rights Commission. “The point is, there were other avenues available to pursue the Charter question; this decision does not cut off the only avenue of relief,” the ruling says. It added of Sturgeon, who represented himself, that “no one has doubted that he acted based on his understanding of his religious obligations,” and that he had “ably advanced his arguments.” “However, despite his sincere and thoughtful arguments, the binding jurisprudence requires that I find against him,” the ruling says.AU, UN Missions Urge South Sudan Parties To Implement Pending Peace Tasks In 2025
Philadelphia Eagles star C.J. Gardner-Johnson facing major NFL punishment decision for obscene gesture after ejection